Key result
Anti-ET gamma-globulin fails to suppress rising blood pressure in spontaneously hypertensive rats.
Why the study?
The pathophysiologic role of endogenous endothelin in the development of hypertension was unclear.
Does repetitive bolus injection of anti-ET gamma-globulin prevent the rise in blood pressure in spontaneously hypertensive rats?
Does repetitive bolus injection of anti-ET gamma-globulin prevent the rise in blood pressure in spontaneously hypertensive rats?
Endogenous endothelin is unlikely to play a key role in the development of hypertension based on this rat model.
Answers are grounded in this paper and cite their sources.
Does not support translation of anti-ET strategies to hypertension prevention; leaves open endothelin’s role pending additional models and human data.
To further elucidate the pathophysiologic role of endogenous endothelin (ET), we have studied the chronic effect of anti-ET gamma-globulin on the development of hypertension in spontaneously hypertensive rats (SHR) and stroke prone SHR (SHR-SP) for three weeks. In neither SHR nor SHR-SP did repetitive bolus injection of anti-ET gamma-globulin suppress the rise in blood pressure. The present data suggest that endogenous ET is not likely to play a key role in the development of hypertension, although ET may induce a local vasoconstriction at the injured vascular wall.
No takes yet. Share an insight, caveat, or question.
Takagi et al. (1991) studied Hypertension. anti-ET gamma-globulin was evaluated on rise in blood pressure. Repetitive bolus injection of anti-ET gamma-globulin did not suppress the rise in blood pressure in spontaneously hypertensive rats or stroke-prone spontaneously hypertensive rats over three weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: